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ABSTRACT – The initial reaction of the body to pathogenic microbial infection or 
severe tissue trauma is an acute inflammatory response. The magnitude of such a response is of 
critical importance, since an uncontrolled response can cause further tissue damage, sepsis, and 
ultimately death, while an insufficient response can result in inadequate clearance of pathogens. 
A normal inflammatory response helps to annihilate threats posed by microbial pathogenic 
ligands, such as endotoxins, and thus, restore the body to a healthy state. Using a personalized 
mathematical model, comprehension and a detailed description of the interactions between pro- 
and anti-inflammatory cytokines can provide important insight in the evaluation of a patient with 
sepsis or a susceptible patient in surgery. Our model is calibrated to experimental data obtained 
from experiments measuring pro-inflammatory cytokines (interleukin-6 (IL-6), tumor necrosis 
factor (TNF-𝛼), and chemokine ligand-8 (CXCL8)) and the anti-inflammatory cytokine 
interleukin-10 (IL-10) over 8 hours in 20 healthy young male subjects, given a low dose 
intravenous injection of lipopolysaccharide (LPS), resulting in endotoxin-stimulated 
inflammation. Through the calibration process, we created a personalized mathematical model 
that can accurately determine individual differences between subjects, as well as identify those 
who showed an abnormal response.  
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INTRODUCTION 
Invasion by disease or injury triggers an acute inflammatory response that is vital in the 
repulsion of the pathogens and the induction of a repair mechanism in damaged tissues. A typical 
inflammatory response consists of the following: 1) phagocytic cells are activated, 2) pro- and 
anti-inflammatory mediators are triggered, 3) the invading pathogen is cleared, 4) the tissue is 
repaired if necessary, and 5) the response is subdued. An insufficient response can lead to 
persistent tissue injury, resulting in conditions such as autoimmune diseases, cancer, and 
lifestyle-related disorders [1]. An uncontrolled, excessive production of pro-inflammatory 
cytokines from immune cells and traumatic tissues can cause systemic inflammatory response 
syndromes such as sepsis and, in life-threatening cases, septic shock [2]. The Agency for 
Healthcare Research and Quality lists sepsis as the most expensive condition treated in U.S. 
hospitals, costing more than $20 billion in 2011 [3]. Toll-like receptor-4 (TLR4) signaling, 
responsible for the production of the inflammatory mediators, may be a key pathway in the 
pathophysiology of sepsis. Thus, understanding TLR4 signaling and the mediators produced is 
critical in evaluating patients experiencing sepsis and those undergoing surgery, such as knee or 
hip replacement, who may be more susceptible to sepsis. 
Experimentalists have studied the inflammatory response in mice and humans through 
the administration of specific pathogens, particularly through endotoxin, a cell wall component 
of gram-negative bacteria. In mice, these studies have provided great insight into the 
inflammatory response. However, due to physiological differences between mice and human 
TLR4 activation [4], a key pathway in the pathophysiology of sepsis, as well as a human’s 
sensitivity to the effects of endotoxin, similar strides have not been made in understanding the 
acute inflammatory response in humans. To quantify the differences in the inflammatory 
responses between mice and humans, Copeland et al. [5] conducted an experiment in which mice 
and humans were given equivalent doses of endotoxin and the levels of circulating cytokines 
TNF-α and IL-6 were measured and compared. The study found that humans experienced a rapid 
physiological response, consisting of fever, tachycardia, and slight hypotension, which was not 
evident in mice. Thus, it was concluded that the autonomic control system is affected by the 
inflammatory response in humans, but likely not in mice. 
Generalized mathematical models of the acute inflammatory response in humans propose 
that the response to endotoxin consists of an instigator and a set of pro- and anti-inflammatory 
mediators working in unison to restore homeostasis [6, 7]. These models are formulated as a 
system of ordinary differential equations set up to integrate known biological assumptions. 
Simple models have the advantage that they allow rigorous mathematical analysis and use 
simplified biological assumptions. Higher-order models [8, 9] have been developed to predict the 
generalized inflammatory response in mice. These include biological complexity predicting the 
dynamics of individual cytokines. However, these models are too complex, both conceptually 
and computationally due to the inherent nonlinearity and the large number of unknown inputs to 
the model to analyze mathematically. 
Our study was motivated by the higher-order model proposed by Clermont et. al. [9] 
predicting the inflammatory response in mice. The model includes neutrophils and macrophages 
directly activated by bacterial endotoxin (E. coli lipopolysaccharide (LPS)) and indirectly via 
systemic stimuli produced by trauma and hemorrhage. The activated phagocytic cells promote 
the production of pro-inflammatory cytokines such as tumor necrosis factor (TNF-𝛼) and 
interleukins 6 and 12 (IL-6, IL-12) and anti-inflammatory cytokines such as IL-10. This model 
was used to reproduce qualitative results from three separate scenarios in mice (trauma, surgical 
trauma/hemorrhage, and 3 and 6 mg/kg of endotoxin). Expanding upon these results, Chow et al. 
[8] developed a 15-state model of the acute inflammatory response in mice to endotoxin, 
hemorrhage, and surgical trauma. Mice were administered endotoxin at levels of 3, 6, or 12 
mg/kg and experimental data was collected—including TNF-α, IL-6, IL-10 and nitric oxide 
byproducts. The insertion of a cannula induced surgical trauma, and hemorrhagic shock was 
stimulated by blood withdrawal. The mathematical model was calibrated to experimental data 
from each of these scenarios. 
Although the model proposed by Chow et al. [8] provided insightful information about 
modeling the dynamics of pro- and anti-inflammatory mediators, their model was designed to 
capture this phenomenon in mice. Furthermore, the majority of mathematical modeling and 
analyses on endotoxin- induced signaling and cytokine production in monocytes and 
macrophages have been done in mice because of the ability to calibrate these models to in vivo 
experimental data. On the contrary, such experiments cannot be easily done in humans since 
endotoxin challenges are potent immunostimulators and are highly regulated in human studies, 
especially in the US. 
In this study, we have developed a personalized mathematical model of the acute 
inflammatory response to endotoxin challenge, based on the biology in humans and the 
interactions between pro- and anti-inflammatory cytokines. This model has the potential to 
advance current understanding in evaluating patients during the early stages of recovery after 
surgery, when many are encouraged to regain mobilization as soon as possible [10]. Our model 
is calibrated to experimental data from 20 healthy young men who were administered an 
intravenous (i.v.) endotoxin dose of 2 ng/kg of body weight. Concentrations of the cytokines IL-
6, CXCL8, TNF-𝛼, and IL-10 were measured hourly for 8 hours. Our model can accurately 
predict the dynamics of these cytokines up to 8 hours after the introduction of the inflammatory 
agent on an individual basis, including those individuals who exhibit an abnormal response. 
 
MATERIALS AND METHODS 
Experimental Data 
Study Participants. Twenty healthy, young male volunteers, between the age of 20 and 33 years 
(median 24.3 years), were recruited via public advertising from the general population in 
Copenhagen, Denmark to participate in this study. The inclusion criteria were as follows: (i) 
male, age 18-35, (ii) good general health, demonstrated by medical history and medical 
examination, (iii) Body Mass Index (BMI) < 30 kg/m2 and (iv) written informed consent prior to 
enrollment. The exclusion criteria were as follows: (i) daily medicine intake (excluding 
antihistamines during pollen season), (ii) smoking or use of nicotine substitutes, (iii) previous 
allergic reaction to nicotine pads, and (iv) previous splenectomy. The study protocol was 
approved by the Regional Committee on Health Research Ethics (protocol-ID H-3-2012-011) 
and the Regional Data Monitoring board (ID j-2007-58-0015, local 30-0766) and reported to 
clinicaltrials.gov (NCT01592526). 
Experimental Procedure/Design. This was an open-label, randomized cross-over study in 
which participants received a bolus of endotoxin at a dose of 2 ng/kg of body weight 2 hours  
after the start of the experiment. Blood samples were collected before the endotoxin infusion (at 
𝑡 = 0) and then at 𝑡 = 2, 3 ,3.5 ,4 hours and in one hour increments for a total of 8 hours.  
FIG 1: Experimental Data. Plasma cytokine responses to intravenous endotoxin administration in 20 healthy young 
men.  Median (black circle), interquartile range (error bars), and subject most in line with data mean (red) are 
depicted. Abnormal response (identified via Box-and-Whisker plots) are denoted by dashed lines. Pro-inflammatory 
cytokines, TNF-𝛼, IL-6, and CXCL8, and the anti-inflammatory cytokine IL-10 levels were measured at t = 0, 2, 3, 
3.5, 4 h and in one hour increments for the next 4 hours. Pseudodata was added at 𝑡 = 9 and 10 to ensure that 
cytokines decayed to baseline levels (blue). Endotoxin was administered at t = 2. 
 
Blood Collection. Blood samples for the analysis of cytokine levels in plasma were 
collected in EDTA tubes (Greiner bio-one, Germany). The samples were kept on ice until 
centrifuged at 4 °C and 3500 rpm for ten minutes. The supernatant was then stored at -80 °C 
until analysis. Cytokine concentrations were analyzed using ELISA (Meso Scale Discovery, 
Rockville, Maryland, USA).  
Data Analysis. Literature shows that in humans, the cytokines take between 6 and 8 hours 
to return to baseline levels after the introduction of a pathogenic agent [5]. Thus, pseudodata was 
added at 𝑡 = 9 and 10, to ensure that the cytokines decayed appropriately. Experimental data 
from all 20 subjects are shown in Fig. 1; pseudodata are shown in blue. The data sets marked in 
red represent the average dynamics of the population, and subsequent personalized simulations 
are shown against this data set. Box-and-whisker plots [11] were used to identify subjects 
displaying an abnormal response among the data sets. 
 
Mathematical Model 
The mathematical model developed here incorporates several key components of the acute 
inflammatory response, including the inflammatory trigger, here called the pathogenic ligand  
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FIG 2: Inflammatory interactions. Intravenous injection of LPS activates circulating monocytes (MR), changing 
them into activated monocytes (MA). This begins the production of TNF-𝛼. At the same time, monocytes are 
activated to produce IL-6 and CXCL8. All three cytokines work in a positive feedback loop, amplifying the 
inflammatory response by activating more monocytes to stimulate production of IL-6, CXCL8, and TNF- 𝛼. 
Moreover, the LPS stimulus, as well as the elevated levels of pro-inflammatory cytokines up-regulate the production 
of IL-10, which inhibits prolonged production of pro-inflammatory cytokines. The solid lines represent up-
regulation, while the dashed line represents down-regulation. 
 
(𝑃), resting and activated monocytes (𝑀𝑅 and 𝑀𝐴 ) and circulating cytokines (TNF-𝛼, IL-6, 
CXCL8, and IL-10). These particular components were analyzed as they are regarded as main 
drivers of the early pro-inflammatory response (TNF-𝛼), the intermediate step between pro- and 
anti-inflammation (IL-6), neutrophil activation (CXCL8), and the late anti-inflammatory 
response (IL-10). The specific role of each component is described in Table 1. The model is 
formulated as a system of seven ordinary differential equations describing the dynamics of the  
pathogenic ligand, monocytes, and circulating cytokines and 43 parameters quantifying their 
interactions, illustrated in Fig. 2.  
Pathogenic ligand. Upon endotoxin injection, the pathogenic ligand is bound to the toll-
like receptor 4 (TLR4) [12, 13] on resting circulating monocytes that will mediate its clearance 
from the body. In this model, the pathogenic ligand was modeled as exponentially decaying with 
an initial value of 2 ng/kg. 
Monocytes. The resting monocytes are formed in the bone marrow, and are released into 
circulation as a means of the ongoing immune activation. The circulating monocytes are  
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FIG 3.    Hill functions. Up- and down-regulation functions (left and right, respectively). The reaction rate, 𝐻, is a 
function of the half-saturation value, 𝑥 , and the substrate concentration, 𝑗. 
 
activated by endotoxin via TLR4 triggering. The circulating activated monocytes trigger the 
production of TNF-𝛼, which is responsible for the recognized signs of inflammation such as 
heat, increased vascular permeability and local swelling, and redness reactions [14]. The TLR4-
mediated activation also leads to the production of IL-6, CXCL8, and IL-10. Moreover, several 
autocrine loops exist where TNF-𝛼 amplifies the inflammatory response by further activating 
monocytes to release pro-inflammatory cytokines, such as IL-6 and CXCL8. TNF-𝛼 also 
encourages the activated monocytes to produce anti-inflammatory cytokines, such as IL-10, 
which exert negative feedback on the system.  
The interactions between the components acting on the resting monocytes are described 
by the following equation 
𝑴𝑹̇ =  −𝑯𝒖𝒑(𝑷)(𝒌𝟏 +  𝒌𝟐𝑯𝒖𝒑(𝑿)) 𝑯𝒅𝒐𝒘𝒏(𝑿) 𝑴𝑹 + 𝒌𝟑𝑴𝑹 (𝟏 −
𝑴𝑹
𝑴∞
⁄ ), (1) 
where 𝑋 ∈ {TNF-α, IL-6, CXCL8, IL-10} and the up- and down-regulation are represented by 
increasing and decreasing Hill functions, 𝐻𝑢𝑝(⋅) and 𝐻𝑑𝑜𝑤𝑛 (⋅), respectively; each Hill function 
ranges between zero and one (see Fig. 3). The resting monocytes are up-regulated by TNF-𝛼 and 
down-regulated by IL-10. The positive feedback of the resting monocytes on themselves is 
accounted for by the additional 𝑀𝑅 in the first term of the equation. The final term of Eq. (1) is 
the natural recruitment and decay of the resting monocytes modeled with a logistic growth term. 
The 𝑘𝑖 terms are rate constants describing activation or elimination rates and 𝑀∞ is the 
maximum number of monocytes present. 
The activated monocytes are represented by  
𝑀𝐴̇ =  𝐻𝑢𝑝(𝑃) (𝑘1 +  𝑘2𝐻𝑢𝑝(𝑋)) 𝐻𝑑𝑜𝑤𝑛 (𝑋) 𝑀𝑅 −  𝑘4𝑀𝐴, (2) 
which is almost identical to Eq. (1), however the first term is positive and the last term is the 
natural decay of the activated monocytes. 
Cytokines. The rate of change of the cytokines can be described as a combination of the 
number of active monocytes present and the influence from the pro- and anti-inflammatory 
cytokines. Mathematically, these interactions can be described by equations of the form 
?̇? =  (𝑘5 +  𝑘6𝐻𝑢𝑝(𝑋)) 𝐻𝑑𝑜𝑤𝑛 (𝑋) 𝑀𝐴 −  𝑘7(𝑋 − 𝑞), (3) 
where, as before, the 𝑘𝑖 terms are rate constants describing activation or elimination rates. The 
down-regulation by the anti-inflammatory cytokine IL-10 (as well as IL-6, which exhibits an 
anti-inflammatory effect on TNF-𝛼 [15, 16]) is modeled by a product of decreasing Hill 
functions in 𝐻𝑑𝑜𝑤𝑛 . The natural source and decay of each cytokine, that is, the behavior of the 
cytokine without the presence of a pathogen ligand, is represented by the last term in Eq. (3). 
The amount of cytokine present in the absence of a pathogen is represented by the source term, 
𝑞. For a complete list of equations, see the APPENDIX. 
TABLE 1: State variables of the mathematical model 
Component Function  Ref. 
Lipopolysaccharide 
(P) 
Derived from gram-negative bacteria; induces inflammation. 
 
[12] 
Resting monocytes 
(MR ) 
Formed in the bone marrow and are specifically transported to 
blood, from where they are recruited to sites of inflammation; 
involved in the recognition, phagocytosis, and destruction of LPS 
and/or pathogens. 
[32, 33] 
Activated monocyte 
(MA ) 
 Produces cytokines when activated by LPS. [32, 33] 
Tumor Necrosis Factor 
(TNF-𝛼) 
Pro-inflammatory. Produced by activated monocytes and other 
phagocytes; amplifies inflammatory cascades; fever inducer; early. 
[8, 12, 15, 
32, 34] 
Interleukin-6 (IL-6 ) Pro-inflammatory. Produced by activated monocytes and other 
phagocytes; fever inducer; early. 
[8, 12, 15, 
16] 
Chemokine Ligand 8  
(CXCL8 ) 
Pro-inflammatory. Attracts white blood cells to the site of 
inflammation; early. 
[12, 18, 35] 
Interleukin-10 (IL-10 ) 
Anti-inflammatory. Limits the inflammatory response; essential for 
homeostasis of the immune system; late. 
[8, 33, 36, 
37] 
 
The mathematical model is comprised of the 7 ordinary differential equations. The state variables are listed in the 
first column. The biological implication of each component and their respective references are shown in columns 2 
and 3. 
Parameterization 
To ensure that our model inputs were physiologically feasible, we studied the relationships 
between those used by Chow et. al, while noting the significant physiological differences 
between mice and humans. For instance, mice and humans differ in their cell surface recognition 
of LPS and downstream signal transduction [12]. These differences prevented a simple scaling to 
change the model from one suitable for mice to one for humans. Keeping these differences in 
mind, we estimated an initial parameter set. 
Initial Parameters. The time constants of the initial parameter set were estimated to 
achieve model output for each cytokine and monocytes that ranged between zero and one. Then 
the maximum values of the human monocytes, obtained from [17], were incorporated through 
scaling to obtain the desired magnitude.  
The half-maximum values of the Hill function were set using experimental data for the 
cytokines, as well as reported data in literature [5, 17-20]. In an approach similar to Clermont et. 
al. [9], for each equation, if cytokine 𝐴 was up-regulating cytokines 𝐵 and 𝐶, then the same half-
maximum value was chosen to represent this interaction in the corresponding equation. That is, if 
the interaction between cytokines (𝐴 & 𝐵) and between (𝐴 & 𝐶) are represented by 
𝐴ℎ𝐵
𝜂𝐵𝐴
ℎ𝐵 + 𝐴𝐵𝐴
ℎ𝐵
     and     
𝐴ℎ𝐶
𝜂𝐶𝐴
ℎ𝐶 + 𝐴𝐶𝐴
ℎ𝐶
, 
respectively, then 𝜂𝐵𝐴 =  𝜂𝐶𝐴.  To find such a value, it was initially chosen to be approximately 
60% of the max value of cytokine 𝐴 from the data. It was then slightly adjusted, either up or 
down, so that the dynamics were more in line with the data. A similar approach was used to find 
the half-maximum values for the down-regulatory interactions. Note that the exponents in each 
sigmoidal equation were able to vary between interactions; that is, ℎ𝐵 ≠ ℎ𝐴. These initial 
parameter values are shown in Table A2 of the APPENDIX. 
 
Model Analysis 
To create a personalized model, an inverse least squares formulation was used to find a 
parameter set that minimized the square of the error between the computed and measured values 
of the cytokines. The residual vector 𝑟 and least squares cost 𝐽 are defined by 
𝐽 =  𝑟𝑇𝑟,      where      𝑟𝑖 =
1
√𝑁
[
𝑥model (𝑖) − 𝑥data(𝑖)
𝑥data(𝑖)̅̅ ̅̅̅ ̅̅ ̅̅
]
𝑇
, (4) 
FIG 4: Ranked Sensitivities. Parameter sensitivities ranked from most to least sensitive. Black line shows cutoff 
between sensitive and insensitive parameters. Red circles denote parameters that were optimized (i.e. sensitive and 
identifiable). 
 
and 𝑁,  𝑥model , 𝑥data and 𝑥data̅̅ ̅̅ ̅̅  are the total number of data points, the model output, the model 
data, and the mean of the model data, respectively.  
Sensitivity Analysis & Subset Selection. Sensitivity analysis separates a parameter set into 
the sensitive and insensitive parameters and is used to lessen the complexity of the optimization 
problem by reducing the parameter set. Generally, a parameter is sensitive if the model output is 
greatly affected following a slight perturbation of said parameter. A parameter is insensitive if 
the model is not affected by large perturbations in the parameter value. This can be a result of the 
structure of the equations as well as the nominal parameter value. A forward difference 
approximation, outlined in [21], was used to compute the relative sensitivities, which were then 
ranked from most to least sensitive. The ranked sensitivities are shown in Fig. 4. 
Using sensitivity analysis, we concluded that 39 of the 43 parameters were sensitive. 
Analyzing the graphs of the Hill functions, shown in Fig. 3, as well as their respective equations, 
𝐻𝑢𝑝(𝑋) =  
𝑋ℎ
𝜂𝑌𝑋
ℎ +  𝑋ℎ
     and      𝐻𝑑𝑜𝑤𝑛(𝑋) =  
𝜂𝑌𝑋
ℎ
𝜂𝑌𝑋
ℎ +  𝑋ℎ
 , 
showed that for 𝜂𝑌𝑋 ≫ 𝑋, 𝐻𝑢𝑝 approached 0, while 𝐻𝑑𝑜𝑤𝑛  approached  1. Conversely, for 𝜂𝑌𝑋 ≪
𝑋, 𝐻𝑢𝑝 approached 1, while 𝐻𝑑𝑜𝑤𝑛  approached 0. Without proper bounds on 𝜂, attempting to fit 
the model to the experimental data forced these values to become either very large or very small, 
depending on the equation. Finding such bounds is not trivial for these equations and our 
particular model. Thus, we choose to keep the half-maximum and their respective exponents 
fixed at their nominal values. Additionally, 𝑀∞and the source terms 𝑞𝑖 of Equation 3 were fixed 
at their nominal vales since they were set based on values found in the literature. 
Based on these adjustments, our parameter set was further reduced from 39 to 14 
sensitive parameters. Subset selection, via the correlation method [22], was used to separate the 
set into identifiable and unidentifiable parameters. A parameter is not identifiable if it is linearly 
dependent of the values of the other parameters in the model. This analysis produced a set of 13 
parameters that were both sensitive and identifiable. 
Parameter Estimation. As previously mentioned, the goal was to find a suitable 
parameter set that minimized the least-squares error given in Equation 4. The parameters were 
estimated using MATLAB’s built-in optimization function fminsearch, a multidimensional 
unconstrained optimizer that uses the Nelder-Mead direct search method [23, 24]. Keeping the 
other parameters fixed, the 13 parameters identified via sensitivity analysis and subset selection 
were estimated. The optimal parameter values as well as their means and standard deviations are 
shown in Table A3 of the APPENDIX. 
Prediction & Confidence Intervals. After obtaining the optimized parameter values, 
prediction and confidence intervals were used to quantify the amount of variation in the 
optimized model. The prediction interval predicts where a single new measurement will be with 
a (1−𝛼) probability at a given time point. It provides information about the distribution of the 
model output values, not the uncertainty associated with determining the population mean. To 
find a prediction interval, let 𝑦?̂?  be an estimate of the model response at time 𝑡 =  ?̂?𝑙, 𝑆 be the 
sensitivity matrix obtained via a forward difference approximation [21] at the times where data 
was collected 𝑡 = (𝑡0, 𝑡1,… , 𝑡𝑁 ), 𝑠
2 be an estimator of 𝜎 2, where the estimated parameters are 
distributed normally with variance 𝜎 2(𝑆𝑇𝑆)−1, and 𝑔𝑖
𝑇  be the 𝑖𝑡ℎ  row of sensitivity matrix 
evaluated at time 𝑡 = (?̂?0, ?̂?1 … , ?̂?𝑟). Note that, in general, (?̂?0, ?̂?1 … , ?̂?𝑟).≠ (𝑡0, 𝑡1, … , 𝑡𝑁 ); that is, 
the time at which the prediction interval is being calculated is different from the time at which 
the data was collected. The prediction interval is then given by  
PI =  𝑦?̂? ± 𝑡𝑁−𝑀
𝛼/2  𝑠(1 + 𝑔𝑖
𝑇(𝑆 𝑇𝑆)−1𝑔𝑖)
1/2, (5) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIG 5.    Experimental data, model predictions, and prediction and confidence intervals. Data and model 
predictions for one subject after intravenous administration of endotoxin (black). Confidence (blue) and prediction 
(red) intervals are also shown. The participant was given 2 ng/kg body weight of endotoxin at 𝑡 = 2, and cytokine 
levels were measured 𝑡 = 2, 3, 3.5, 4, and hourly for the next 4 hours. Pseudodata was added at 𝑡 = 9 and 𝑡 = 10 to 
ensure that cytokines had appropriate time to decay. 
 
where 𝑁 is the total number of data points, 𝑀 is the number of parameters being estimated, and 
𝑡𝑁−𝑀
𝛼/2
 is the (1 − 𝛼/2) quantile of a Student t-distribution with 𝑁 − 𝑀 degrees of freedom. For 
our analysis, we were interested in the 95% prediction interval so 𝛼 = 0.05.  
The confidence interval measures the uncertainty of the model in predicting the mean 
response and is given by the following expression  
CI =  𝑦?̂? ± 𝑡𝑁−𝑀
𝛼 /2  𝑠(𝑔𝑖
𝑇(𝑆𝑇𝑆)−1𝑔𝑖)
1/2. (6) 
Comparing Eqs. (5) and (6), it is noted that the prediction interval is wider than the 
confidence interval. The derivation of Eqs. (5) and (6) can be found in [25]. Note that in Eq. (6), 
the second term will be 0 at 𝑡 = 𝑡0  since 𝑔𝑖
𝑇 = 0, due to the initial conditions. In Fig. 1, we 
highlighted the data from the subject that represented the average dynamics of the population. 
The model predictions along with the confidence and prediction intervals for this subject are 
shown in Fig. 5. Note that due to the nature of the equations, the prediction and confidence 
interval may be negative, but in practice cytokine levels are always positive.  
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RESULTS 
As illustrated in Fig. 5, the intravenous injection of LPS gives rise to rapid production of 
measurable cytokines in the blood stream. This response was observed to take 45 minutes to an 
hour to occur. Note that Fig. 5 shows the dynamics of the cytokines after the injection of LPS. 
Each subject was given LPS at 𝑡 = 2, thus the graphs also start at 𝑡 = 2. Monocytes make up the 
main cell subset within the blood to respond to LPS stimulation [26]. Upon binding of LPS to 
TLR4, the monocytes will become activated and respond with production of cytokines where 
some will be secreted rapidly after activation, while others require de novo biosynthesis, and will 
have a longer response time. The circulating activated monocytes induce the production of TNF-
𝛼, at 1.5 to 2 hours after the initial injection of LPS. The activated monocytes also begin 
production of IL-6 and CXCL8 at 2 to 2.5 hours after the injection. The anti-inflammatory 
cytokine IL-10 makes a later appearance [12] than the pro-inflammatory cytokines, being 
measurable at 2.75 to 3 hours upon LPS exposure. This production inhibits continuous 
inflammation. Evidence of this is shown in the fact that the time at which the pro-inflammatory 
cytokines began to decrease coincides with the time that IL-10 peaked, around 2.25 to 2.75 
hours. Once the LPS is cleared from the bloodstream, the cytokines will return to their baseline 
levels. 
 The optimized parameter values are shown in Table A3. We used the prediction and 
confidence intervals shown in Fig. 5 to quantify the accuracy of the model and the parameters 
ability to depict the data. Individual response data that discern from the mean data set are 
identified as dashed lines in Fig. 1. The model prediction for an individual showing an abnormal 
response along with the mean data set is shown in Fig. 6.  
 
Statistical Assessment 
The 𝑅2 statistic was used to quantify the ability of the model to accurately depict the 
data. When fitting the model to the mean of the available data, we obtained 𝑅2 values of 0.91, 
0.9, 0.97, and 0.97 for TNF-𝛼, IL-10, IL-6, and CXCL8 respectively. Thus, we can conclude that 
the model presents an overall good fit to the data. The prediction and confidence interva ls shown 
in Fig. 5 show that the model accurately depicts the mean response and that the optimized 
parameter values provide a reasonable prediction of the data. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIG 6.    Model predictions for the mean data set and an abnormal individual response data set. Mean data set 
(black circles), model predictions for the mean data set (black line), interquartile range (error bars),  and model 
predictions for an abnormal data set (blue line), are shown. Participants were given 2 ng/kg body weight of 
endotoxin at 𝑡 = 2, and cytokine levels were measured 𝑡 = 2, 3, 3.5, 4, and hourly for the next 4 hours. Pseudodata 
was added at 𝑡 = 9 and 𝑡 = 10 to ensure that cytokines had appropriate time to decay. 
 
DISCUSSION 
In this study we generated a personalized cytokine response model based on systemic 
measures of cytokine production after low dose i.v. endotoxin injection in healthy men.  The 
specific constraints related to individual response levels made it necessary to build a 
personalized model. Biological variations as the one seen in the data set shown in Fig. 6 is a 
common phenomenon in individuals responding to LPS, and therefore it is of great importance to 
be able to model all individual response types. It is clear that the response in the abnormal 
subject is significantly different than that of the mean data set for TNF-𝛼, IL-10, and IL-6. This 
could be due to the fact that IL-6 has an anti-inflammatory effect on TNF-𝛼 [2, 16], so a high 
level of IL-6 can result in lower levels of TNF-𝛼. Additionally, TNF-𝛼 and IL-10 have opposing 
roles in the inflammatory response, which can lead to a high level of IL-10 when TNF-𝛼 is low. 
Such differences in cytokine response patterns in monocytes to LPS stimulation have been 
studied at the molecular level in ex vivo stimulation assays. Based on these studies, it appears 
that individual differences in the expression and regulation of the interferon regulatory factor 3 
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pathway may play a role in regulating the level of specific cytokine production after LPS 
activation [27]. 
These differences in the responses also caused noteworthy contrasts in the parameter 
values. For instance, 𝑘6𝑀 , the rate responsible for the amount of up-regulation of IL-6 from the 
activated monocytes, was much larger for abnormal response data (mean sets: 0.293, abnormal 
set: 1.33). As expected, this resulted in much higher levels for IL-6. Conversely, 𝑘6𝑇𝑁𝐹 , the rate 
responsible for the amount of  TNF-𝛼 secreted from activated monocytes, was lower in the 
abnormal response set (mean sets: 1, abnormal set: 0.342). This can explain the lower levels of 
TNF-𝛼 measured in this individual.  
One of the limitations of the model was the sparseness of the available data points. The 
majority of the changes in the dynamics of the system occur between 1 and 3 hours after the 
administration of LPS. Thus, having more data points available during those times, perhaps 
every 15 minutes, may have provided more accurate results. For example, we expect TNF-𝛼 to 
peak 1.5 to 2 hours after the subject is given LPS. However, because the data was collected with 
30 min intervals, at times t = 1, 1.5, 2 hours we cannot predict exactly when the cytokine level 
peaks. Additionally, having data for the numbers of circulating resting and activated monocytes 
may have provided insight as to why a particular subject has a specific response to the endotoxin 
versus another since the monocytes are responsible for the measured cytokine cascade. Another 
limitation was estimating the parameters in the Hill functions. To make the model personalized, 
we may require different half-maximum values and exponents for each subject. However, we 
were unable to find an effective way to estimate them without having the Hill functions operate 
on the tail end (close to either one or zero). 
 Besides the modeling of direct triggering of IL-10 production after TLR4 ligation by 
LPS, previous models [8] have also included an interaction between IL-10 and TNF-𝛼 in which 
IL-10 is up-regulated by TNF-𝛼. However, biological evidence supporting this claim has not 
been found, which leads us to believe that it might not be a direct interaction. Instead, it could be 
that the up-regulation of IL-6 from TNF-𝛼 [15, 28] induces an increase in the levels of IL-10. To 
investigate this, sensitivity analysis, subset selection, and optimization were performed on a new 
model containing the interaction between IL-10 and TNF-𝛼. Once a suitable parameter set and 
model fit were obtained, the Akaike Information Criterion (AIC), a model selection tool used to 
compare different models quantitatively [29], was used to measure the goodness of fit with and 
without that interaction. AIC measures the amount of information lost when a given model is 
used to describe the behavior of a system, so the smaller the value the better. Table A4 shows the 
calculated AIC values for the model with and without IL-10 being up-regulated by TNF-𝛼. The 
AIC values along with each model’s prediction of the data, led to the conclusion that it would be 
best to omit this hypothetical/possible pathway.  
Although we chose to study TNF-𝛼, IL-6, CXCL8, and IL-10, there are many other 
important cytokines and factors involved in the inflammatory process. For example, IL-1𝛽 is 
considered one of the most important pro-inflammatory cytokines released from monocytes upon 
LPS-induced activation [12] and nitric oxide promotes inflammation and tissue injury [8, 14]. 
Additionally, the endotoxin-signaling pathway has been shown to involve lipopolysaccharide-
binding protein (LBP), and the co-activators myeloid differentiation-2 (MD-2), and CD14, as 
well as TLR4. Each signaling pathway has a specific reaction time that may be dependent on the 
dose of endotoxin, the availability of co-activators as well as the specific cytokine being 
activated. For instance, Blomkalns et al. [30] found that the release of CXCL8 by freshly isolated 
human PBMCs given a low dose of endotoxin was dependent on both membrane-associated 
CD14 and TLR4. In addition, it has been found that recognition by a specific receptor cluster is 
associated with the strain of bacteria [31]. To increase the accuracy of our model, we need to 
identify the specific pathways activated and the time necessary for production of the specific 
cytokine, and then incorporate these factors into our model. 
In conclusion, we have developed a personalized mathematical model of the 
inflammatory response in humans. This model was built on sequential measures of cytokines in 
circulating blood, but might be connected to highly correlated parameters that are more easily 
monitored in patients during early postoperative mobilization. Despite having sparse data and 
difficulties in estimating certain parameters, we were able to make a personalized model. In 
addition to cytokine levels, we also have blood pressure and heart rate data available from this 
experiment. We hope to expand the current model to include blood pressure and heart rate, 
which can provide an idea of why some patients faint after surgery while others do not. This may 
lead to the development of preoperative therapy that can be used to shorten a patient’s hospital 
stay, reducing heath care costs and improving patient’s quality of life. 
 
 
 
APPENDIX 
Model Equations 
Below are the differential equations modeling the dynamics of the inflammatory 
response; they represent the interactions depicted in Fig. 1. Each up- or down-regulation is 
represented by a sigmoidal function of the form 
𝐻𝑌
𝑈(𝑋) =  
𝑋ℎ
𝜂𝑌𝑋
ℎ +  𝑋ℎ
     or       𝐻𝑌
𝐷(𝑋) =  
𝜂𝑌𝑋
ℎ
𝜂𝑌𝑋
ℎ +  𝑋ℎ
 , 
respectively. Here, 𝑋 is the cytokine (or pathogenic ligand, in the case of the monocytes) 
responsible for either up- or down-regulating component 𝑌. The half-maximum value is 
represented by 𝜂𝑌𝑋  and the associated exponent is ℎ. These functions are non-dimensional and 
range between zero and one. The nominal parameter values and units are shown in Table A2.  
 
TABLE A1: State variables and equations of the mathematical model  
Pathogen 
𝑑𝑃
𝑑𝑡
=  −𝑘𝑃 𝑃 
Resting 
Monocytes 
𝑑𝑀𝑅
𝑑𝑡
=  −𝐻𝑀
𝑈 (𝑃)(𝑘𝑀 + 𝑘𝑀TNF𝐻𝑀
𝑈 (TNF)) 𝐻𝑀
𝐷 (IL10) 𝑀𝑅 +  𝑘𝑀𝑅 𝑀𝑅 (1 −
𝑀𝑅
𝑀∞
⁄ ) 
Activated 
Monocytes 
𝑑𝑀𝐴
𝑑𝑡
= 𝐻𝑀
𝑈 (𝑃)(𝑘𝑀 + 𝑘𝑀TNF𝐻𝑀
𝑈 (𝑇𝑁𝐹)) 𝐻𝑀
𝐷 (IL10) 𝑀𝑅 −  𝑘𝑀𝐴 𝑀𝐴  
Interleukin-6 
𝑑IL6
𝑑𝑡
=  (𝑘6𝑀 + 𝑘6TNF 𝐻IL6
𝑈 (TNF)) 𝐻IL6
𝐷 (IL6) 𝐻IL6
𝐷 (IL10) 𝑀𝐴 − 𝑘6 (IL6 − 𝑞IL6) 
Tumor 
Necrosis 
Factor 
𝑑TNF
𝑑𝑡
= 𝑘TNF𝑀  𝐻TNF
𝐷 (IL6)𝐻TNF
𝐷 (IL10)𝑀𝐴 − 𝑘TNF (TNF − 𝑞TNF) 
CXCL8 
𝑑IL8
𝑑𝑡
=  (𝑘8𝑀 +  𝑘8TNF𝐻IL8
𝑈 (TNF)) 𝐻IL8
𝐷 (IL10)𝑀𝐴 −  𝑘8(IL8 − 𝑞IL8) 
Interleukin-10 
𝑑IL10
𝑑𝑡
=  (𝑘10𝑀 + 𝑘106 𝐻IL10
𝑈 (IL6))𝑀𝐴 − 𝑘10 (IL10 − 𝑞IL10). 
 
 
  
TABLE A2: Nominal parameter values and units 
No. Parameter Value Unit No. Parameter Value Unit 
1 𝑘10 0.8 ℎ𝑟
−1 23 ℎ106  3.68 - 
2 𝑘10𝑀  0.0191 
𝑝𝑔
𝑚𝐿 ∙ ℎ𝑟 ∙ # 𝑜𝑓 𝑐𝑒𝑙𝑙𝑠
 24 ℎ6𝑇𝑁𝐹  2 
- 
3 𝑘6 0.66 ℎ𝑟
−1 25 ℎ66  1 - 
4 𝑘6𝑀  0.81 
𝑝𝑔
𝑚𝐿 ∙ ℎ𝑟 ∙ # 𝑜𝑓 𝑐𝑒𝑙𝑙𝑠
 26 ℎ610 4 
- 
5 𝑘8 0.66 ℎ𝑟
−1 27 ℎ8𝑇𝑁𝐹  3 - 
6 𝑘8𝑀  0.56 
𝑝𝑔
𝑚𝐿 ∙ ℎ𝑟 ∙ # 𝑜𝑓 𝑐𝑒𝑙𝑙𝑠
 28 ℎ810 1.5 
- 
7 𝑘𝑇𝑁𝐹  1 ℎ𝑟
−1 29 ℎ𝑇𝑁𝐹10  3 - 
8 𝑘𝑇𝑁𝐹𝑀  0.6 
𝑝𝑔
𝑚𝐿 ∙ ℎ𝑟 ∙ # 𝑜𝑓 𝑐𝑒𝑙𝑙𝑠
 30 ℎ𝑇𝑁𝐹6 2 
- 
9 𝑘𝑀𝐴  2.51 
ℎ𝑟−1 
 
31 ℎ𝑀10  0.3 
- 
10 𝑘𝑀𝑅  0.006 ℎ𝑟
−1 32 ℎ𝑀𝑇𝑁𝐹  3.16 - 
11 𝑘𝑃  1.01 ℎ𝑟
−1 33 ℎ𝑀𝑃  1 - 
12 𝜂610  34.8 𝑝𝑔/𝑚𝐿  34 𝑞𝑇𝑁𝐹  1.08 𝑝𝑔/𝑚𝐿 
13 𝜂66 560 𝑝𝑔/𝑚𝐿  35 𝑞𝐼𝐿10 0.248 𝑝𝑔/𝑚𝐿 
14 𝜂6𝑇𝑁𝐹  185 𝑝𝑔/𝑚𝐿  36 𝑞𝐼𝐿8 1.42 𝑝𝑔/𝑚𝐿 
15 𝜂810  17.4 𝑝𝑔/𝑚𝐿  37 𝑞𝐼𝐿6 0.317 𝑝𝑔/𝑚𝐿 
16 𝜂8𝑇𝑁𝐹  185 𝑝𝑔/𝑚𝐿  38 𝑘𝑀  0.0414 ℎ𝑟
−1 
17 𝜂106 560 𝑝𝑔/𝑚𝐿  39 𝑀∞  30000 # 𝑜𝑓 𝑐𝑒𝑙𝑙𝑠  
18 𝜂𝑇𝑁𝐹10 17.4 𝑝𝑔/𝑚𝐿  40 𝑘6𝑇𝑁𝐹  0.81 
𝑝𝑔
𝑚𝐿 ∙ ℎ𝑟 ∙ # 𝑜𝑓 𝑐𝑒𝑙𝑙𝑠
 
19 𝜂𝑇𝑁𝐹6 560 𝑝𝑔/𝑚𝐿  41 𝑘8𝑇𝑁𝐹  0.56 
𝑝𝑔
𝑚𝐿 ∙ ℎ𝑟 ∙ # 𝑜𝑓 𝑐𝑒𝑙𝑙𝑠
 
20 𝜂𝑀𝑃  3.3 𝑛𝑔/𝑘𝑔 42 𝑘106  0.0191 
𝑝𝑔
𝑚𝐿 ∙ ℎ𝑟 ∙ # 𝑜𝑓 𝑐𝑒𝑙𝑙𝑠
 
21 𝜂𝑀10  4.35 𝑝𝑔/𝑚𝐿  43 𝑘𝑀𝑇𝑁𝐹  8.65 ℎ𝑟
−1 
22 𝜂𝑀𝑇𝑁𝐹  100 𝑝𝑔/𝑚𝐿      
 
 
  
TABLE A3: Optimal parameter values.  
Parameter 
Nominal 
Value 
Optimized 
Value 
Mean ±Standard 
Deviation 
𝒌𝟏𝟎𝑴 0.019 0.028 0.017 ± 0.011 
𝒌𝟏𝟎 0.8 1.10 0.899 ± 0.230 
𝒌𝟔 0.66 0.903 0.947 ± 0.315 
𝒌𝟔𝑴 0.81 0.295 0.481 ± 0.282 
𝒌𝟖 0.66 0.857 0.883 ± 0.258 
𝒌𝑻𝑵𝑭 1 2.22 1.74 ± 0.524 
𝒌𝑻𝑵𝑭𝑴  0.6 1 0.798 ± 0.276 
𝒌𝑴𝑨 2.51 2.32 2.88 ± 1.37 
𝒌𝑷 1.01 0.631 0.641 ± 0.331 
𝒌𝟔𝑻𝑵𝑭 0.81 1 1.18 ± 0.581 
𝒌𝟖𝑻𝑵𝑭 0.56 1.50 0.830 ± 0.697 
𝒌𝟏𝟎𝟔 0.0191 3.65e-4 0.012 ± 0.020 
𝒌𝑴𝑻𝑵𝑭  8.65 2.97 7.69± 9.97 
Optimal parameter values and mean plus/minus standard deviation excluding abnormal data sets 
shown in Figure 1. 
 
  
TABLE A4.    Akaike Information Criterion Results. 
 without interaction with interaction 
TNF-𝜶 99.435 108.977 
IL-6 105.887 114.929 
IL-8 110.812 118.333 
IL-10 77.648 87.4316 
AIC values for model without TNF-𝛼 up-regulating IL-10 (column 2), and a model with the 
interaction (column 3). Values shown in bold indicate lowest value for particular state variable 
and model.  
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FIGURE LEGENDS 
 
FIG 1. Experimental Data. Plasma cytokine responses to intravenous endotoxin administration 
in 20 healthy young men.  Median (black circle), interquartile range (error bars), and subject 
most in line with data mean (red) are depicted. Abnormal response (identified via Box-and-
Whisker plots) are denoted by dashed lines. Pro-inflammatory cytokines, TNF-𝛼, IL-6, and 
CXCL8, and the anti-inflammatory cytokine IL-10 levels were measured at t = 0, 2, 3, 3.5, 4 h 
and in one hour increments for the next 4 hours. Pseudodata was added at 𝑡 = 9 and 10 to ensure 
that cytokines decayed to baseline levels (blue). Endotoxin was administered at t = 2. 
 
FIG 2: Inflammatory interactions. Intravenous injection of LPS activates circulating 
monocytes (MR), changing them into activated monocytes (MA). This begins the production of 
TNF-𝛼. At the same time, monocytes are activated to produce IL-6 and CXCL8. All three 
cytokines work in a positive feedback loop, amplifying the inflammatory response by activating 
more monocytes to stimulate production of IL-6, CXCL8, and TNF- 𝛼. Moreover, the LPS 
stimulus, as well as the elevated levels of pro-inflammatory cytokines up-regulate the production 
of IL-10, which inhibits prolonged production of pro-inflammatory cytokines. The solid lines 
represent up-regulation, while the dashed line represents down-regulation. 
 
FIG 3.    Hill functions. Up- and down-regulation functions (left and right, respectively). The 
reaction rate, 𝐻, is a function of the half-saturation value, 𝑥, and the substrate concentration, 𝑗. 
 
FIG 4: Ranked Sensitivities. Parameter sensitivities ranked from most to least sensitive. Black 
line shows cutoff between sensitive and insensitive parameters. Red circles denote parameters 
that were optimized (i.e. sensitive and identifiable). 
 
FIG 5.    Experimental data, model predictions, and prediction and confidence intervals. 
Data and model predictions for one subject after intravenous administration of endotoxin (black). 
Confidence (blue) and prediction (red) intervals are also shown. The participant was given 2 
ng/kg body weight of endotoxin at 𝑡 = 2, and cytokine levels were measured 𝑡 = 2, 3, 3.5, 4, and 
hourly for the next 4 hours. Pseudodata was added at 𝑡 = 9 and 𝑡 = 10 to ensure that cytokines 
had appropriate time to decay. 
 
FIG 6.    Model predictions for the mean data set and an abnormal individual response data 
set. Mean data set (black circles), model predictions for the mean data set (black line), 
interquartile range (error bars),  and model predictions for an abnormal data set (blue line), are 
shown. Participants were given 2 ng/kg body weight of endotoxin at 𝑡 = 2, and cytokine levels 
were measured 𝑡 = 2, 3, 3.5,4, and hourly for the next 4 hours. Pseudodata was added at 𝑡 = 9 
and 𝑡 = 10 to ensure that cytokines had appropriate time to decay. 
 
